Skip to main content

DNA

‘Detangler’ binds, bends and cuts DNA

Mar. 2, 2012—New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.

Read more


Offspring of childhood cancer survivors have no increased risk for birth defects

Dec. 15, 2011—Children of childhood cancer survivors who were treated with radiation or some forms of do not have an increased risk for birth defects compared to children of cancer survivors who did not receive such treatments.

Read more


Yaqiong Xu receives NSF career development award

Oct. 25, 2011—Electrical engineer and physicist Yaqiong Xu has received a prestigious career development award to study a new class of molecules called nanobiohybrids.

Read more


Fungus toxin gets in the way in DNA

Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.

Read more


Number of genes associated with MS doubled

Aug. 10, 2011—An international team of scientists has identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of an important and very debilitating neurological disease.

Read more


The Possibilities of Personalized Medicine

Jan. 31, 2010—What if your doctor could tell by reading your genetic code which drugs were most likely to work for you, and which you should avoid, even before you try them? What if a “genetic biopsy” taken from your cancer could pinpoint the treatment most likely to kill the tumor, and with the fewest side effects?...

Read more


Upcoming Events

MORE EVENTS »